| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 07/01/2004 | US20040127485 1,4! - diazepane -1- carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127468 phosphatidic acid decreases apoptosis induced by the sudden withdrawal of NGF and serum (trophic withdrawal), rotenone, and glutamate |
| 07/01/2004 | US20040127413 for treatment of malnourished subjects or those in hypercatabolism condition |
| 07/01/2004 | US20040127400 for inducing antibody production against Streptococcal antigens |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126424 comprises stiffening agents for ameliorating side effects associated with adminstration of lipase inhibitors (anal leakage of undigested fat or oil); for treatment of diabetes |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | CA2509611A1 Method of treatment for sexual dysfunction |
| 07/01/2004 | CA2509600A1 Pharmaceutical uses for alpha2delta ligands |
| 07/01/2004 | CA2508838A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 07/01/2004 | CA2508818A1 Methods of using a beverage composition |
| 07/01/2004 | CA2508297A1 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 07/01/2004 | CA2505788A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 06/30/2004 | EP1433783A2 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432735A2 Antagonistic anti-htnfsf13b human antibodies |
| 06/30/2004 | EP1432730A2 Glucagon-like peptide-1 analogs |
| 06/30/2004 | EP1432724A1 Rna interference mediated inhibition of map kinase genes |
| 06/30/2004 | EP1432723A2 Modulation of the expression of genes dependent on stat-1 |
| 06/30/2004 | EP1432715A2 Pyrimidine derivatives |
| 06/30/2004 | EP1432703A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432700A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 06/30/2004 | EP1432454A2 Methods for sterilizing preparations containing albumin |
| 06/30/2004 | EP1432452A2 Inhibition of stat-1 |
| 06/30/2004 | EP1432435A1 Enamel matrix protein compositions for modulating immune response |
| 06/30/2004 | EP1432430A2 Pre-mixes of glp-1 and basal insulin |
| 06/30/2004 | EP1432421A1 Quinoline derivatives as neuropeptide y antagonists |
| 06/30/2004 | EP1432418A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 06/30/2004 | EP1313379B1 Alpha-(1,4)linked glucose polymers containing oral compositions to alleviate or prevent tooth damage |
| 06/30/2004 | EP1214313B1 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/30/2004 | EP1149072B1 Sulfonamide hydroxamates |
| 06/30/2004 | EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 06/30/2004 | EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES |
| 06/30/2004 | EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | EP0851876B1 Antisecretory factor peptides regulating pathological permeability changes |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509283A Novel pyridyl cyanoguandine compounds |
| 06/30/2004 | CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509176A Cathartic composition |
| 06/30/2004 | CN1509175A Novel Use |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1509164A System for delivering consmetics and pharmaceuticals. |
| 06/30/2004 | CN1509155A Artificial kidney having function of metabolizing profein and method of constituting same |
| 06/30/2004 | CN1509144A Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 06/30/2004 | CN1508136A Tetrahydropyrido compound |
| 06/30/2004 | CN1508133A Red-rooted salvia root anti-peptic ulcer effective site and preparing process thereof |
| 06/30/2004 | CN1508131A Ferrous orotic acid, and preparing method and use thereof |
| 06/30/2004 | CN1507911A Medicine for activating meridians and clearing brain and preparing method thereof |
| 06/30/2004 | CN1507899A Chinese medicine composition and preparing method thereof |
| 06/30/2004 | CN1507896A Chinese medicime liposome for treating viral hepatitis B and preventing liver cell from fibriform and preparing method thereof |
| 06/30/2004 | CN1507895A Medicine for anti consumptive disease |
| 06/30/2004 | CN1507894A Medicine for treating gastrointestinal summer damp cold and preparing method thereof |
| 06/30/2004 | CN1507886A Chinese medicine for enteric recovery |
| 06/30/2004 | CN1507869A Combined preparation containing morpholine anthracyclines and anticancer agent |
| 06/30/2004 | CN1507861A Trimebutine maleate tablet and preparing method thereof |
| 06/30/2004 | CN1155697C Lactobacillus bifidus growth promoting composition and use thereof |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155598C Tetrahydropyridoethers |
| 06/30/2004 | CN1155597C Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties |
| 06/30/2004 | CN1155596C New phenylpiperazines |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155400C Chinese herbal medicine formula for curing cholecystitis |
| 06/30/2004 | CN1155393C Application of 6-0-carboxymethyl chitosan in treating gastritis and gastric ulcer |
| 06/30/2004 | CN1155380C Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis |
| 06/30/2004 | CN1155369C Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 06/30/2004 | CN1155363C Composition for treatment of halitosis |
| 06/30/2004 | CN1155362C Toothpaste comprising fine and coarse calcium carbonate |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756398 Positive modulators of nicotinic receptor agonists |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |